FWCC-Biorepository, United States

Registration Status: Pending

Objective: The biorepository, a Feist-Weiller Cancer Center (FWCC) supported resource, provides a gateway through which investigators, involved in an IRB-approved research project or clinical trial, can acquire human tissue samples and/or hematological specimens to support their research. The overall goal of FWCC – Biorepository is to support translational research by functioning as the primary fresh-frozen tissue acquisition and processing facility for human solid tissue and hematopoietic specimens. In support of future research studies, the FWCC Biorepository utilizes an IRB-approved protocol to procure remnant tissue, blood, or other body fluids from consented patients for research purposes. Additionally, FWCC – Biorepository provides customized services and equipment to assist investigators in the procurement, analyses, and clinicopathologic correlation of human tissue specimens.

Registered Biobank Name	FWCC-Biorepository
Biobank Leader	Jimi Murph
Country	United States
Email for biobank inquiries	jimi.murph@lsuhs.edu
Principal Investigator	Ellen Friday, PhD, QBRS(ASCP)cm
Website
User Type Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper

Biospecimen Collected:

Cohort Highlights

100 cases Next Generation Sequencing assay to detect all classes of genetic variant in Lung Cancer using a single Diagnostic test.
200 cases Colorectal TMA for QC purposes in support of study of tumor infiltrating lymphocytes in ovarian cancer tissues.
Build 300 cases breast cancer TMA containing primary tumour and matched metastatic LN for various subtypes (luminal, HER2, Triple negative). Start with Triple negatives.
125 cases Breast tumour and metastatic lymph nodes in breast cancer cases with outcomes of metastasis to lung or bone.
100 cases of rare tumours - fibrolamellar hepatocellular carcinoma. FFPE, frozen, BC.
200 cases of FFPE tissue sections from breast, lung adenocarcinoma, and lung squamous cell carcinoma with matching normal tissue (only pathology data requested).